Anti-CTLA-8 / IL-17a Reference Antibody (UCB patent anti-IL-17)
- Product Code: 139983
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Used in the treatment of autoimmune diseases such as psoriasis, psoriatic arthritis, and ankylosing spondylitis by neutralizing IL-17A, a pro-inflammatory cytokine involved in chronic inflammation. This antibody helps reduce inflammation, slow disease progression, and improve symptoms by blocking the interaction of IL-17A with its receptor. It serves as a reference in developing biosimilars and evaluating new anti-IL-17 therapies. Also utilized in preclinical research to study IL-17 pathway mechanisms and validate therapeutic targets.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50μg | 10-20 days | ฿4,980.00 |
+
-
|
Anti-CTLA-8 / IL-17a Reference Antibody (UCB patent anti-IL-17)
Used in the treatment of autoimmune diseases such as psoriasis, psoriatic arthritis, and ankylosing spondylitis by neutralizing IL-17A, a pro-inflammatory cytokine involved in chronic inflammation. This antibody helps reduce inflammation, slow disease progression, and improve symptoms by blocking the interaction of IL-17A with its receptor. It serves as a reference in developing biosimilars and evaluating new anti-IL-17 therapies. Also utilized in preclinical research to study IL-17 pathway mechanisms and validate therapeutic targets.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :